DAFALGAN Side Effects

6614735-3 | Hepatitis, Multi-organ Failure
on Feb 21, 2010 Female patient from BELGIUM , 43 years of age, weighting 154.3 lb, was treated with Dafalgan (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), multi-organ failure. Dafalgan dosage: 1 G, Qid. During the same period patient was treated with KETOROLAC TROMETHAMINE (30 Mg, Unk) (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ). Patient was hospitalized.

6426249-4 | Abortion Induced, Pregnancy
Patient was taking Dafalgan (View Usage). Patient had the following side effects: abortion induced, pregnancy (What is pregnancy?) on Oct 29, 2009 from SWITZERLAND Additional patient health information: Female patient , 37 years of age, was diagnosed with pain (What is pain?), bipolar disorder (What is bipolar disorder?), anxiety disorder, extrapyramidal disorder and. Dafalgan dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), DEPAKENE (View Depakene Review and Depakene Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), SIFROL (View Sifrol Review and Sifrol Label ).

5478328-6 | Haematoma
Adverse event was reported on Oct 02, 2007 by a Female patient taking Dafalgan (View Usage) (Dosage: ) was diagnosed with pain in extremity, cardiac disorder, hypertension, varicose ulceration and. Location: FRANCE , 71 years of age, After Dafalgan was administered, patient had the following side effects: haematoma. During the same period patient was treated with PRAVADUAL TABS (View Pravadual Tabs Review and Pravadual Tabs Label ), PREVISCAN (View Previscan Review and Previscan Label ), TENORMIN (View Tenormin Review and Tenormin Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), NUREFLEX (View Nureflex Review and Nureflex Label ), LAMALINE (View Lamaline Review and Lamaline Label ).

5350904-0 | Haematoma
on Jun 04, 2007 Female patient from FRANCE , 71 years of age, was diagnosed with pain in extremity, cardiac disorder, hypertension, varicose ulceration and was treated with Dafalgan (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma. Dafalgan dosage: . During the same period patient was treated with PRAVADUAL TABS (View Pravadual Tabs Review and Pravadual Tabs Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PREVISCAN (View Previscan Review and Previscan Label ), TENORMIN (View Tenormin Review and Tenormin Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), NUREFLEX (View Nureflex Review and Nureflex Label ).


5173989-3 | Agitation, Bronchopneumonia, Cough, Gastrooesophageal Reflux Disease, Grand Mal Convulsion, Hypocalcaemia, Hypothyroidism, Overdose
on Sep 01, 2006 Female patient from SWITZERLAND , 70 years of age, was diagnosed with pain (What is pain?), sleep disorder (What is sleep disorder?), cough, hypercalcaemia of malignancy, bronchopneumonia and was treated with Dafalgan (View Usage). Patient had the following side effects: agitation, bronchopneumonia, cough, gastrooesophageal reflux disease, grand mal convulsion, hypocalcaemia, hypothyroidism, overdose. Dafalgan dosage: 4000 Mg/d. During the same period patient was treated with ACIDUM FOLICUM STREULI (5 Mg/d) (View Acidum Folicum Streuli Review and Acidum Folicum Streuli Label ), DISTRANEURIN (300 Mg/d) (View Distraneurin Review and Distraneurin Label ), RESYL (60 Drops/d) (View Resyl Review and Resyl Label ), HAEMODIALYSIS (View Haemodialysis Review and Haemodialysis Label ), ZOMETA (4 Mg) (View Zometa Review and Zometa Label ), DEXAMETHASONE (40 Mg) (View Dexamethasone Review and Dexamethasone Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), MERONEM (500-2000 Mg/d) (View Meronem Review and Meronem Label ). Patient was hospitalized.

5117233-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Gamma-glutamyltransferase Increased, Hepatitis, Hyperbilirubinaemia, Jaundice
Patient was taking Dafalgan (View Usage). After Dafalgan was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?), hyperbilirubinaemia, jaundice (What is jaundice?) on Jul 28, 2006 from FRANCE Additional patient health information: Female patient , 68 years of age, weighting 207.2 lb, was diagnosed with pyelonephritis and. Dafalgan dosage: 3 G, Qd. During the same period patient was treated with OFLOCET (400 Mg, Qd) (View Oflocet Review and Oflocet Label ), BISOPROLOL FUMARATE (10 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RIFADIN (300 Mg, 6qd) (View Rifadin Review and Rifadin Label ), AMLOR (5 Mg, Qd) (View Amlor Review and Amlor Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ), ORACEFAL (View Oracefal Review and Oracefal Label ). Patient was hospitalized.

5105427-0 | Agitation, Bronchopneumonia, Cough, Gastrooesophageal Reflux Disease, Grand Mal Convulsion, Hypocalcaemia, Hypothyroidism, Overdose
Adverse event was reported on Sep 01, 2006 by a Female patient taking Dafalgan (View Usage) (Dosage: 4000 Mg/d) was diagnosed with pain (What is pain?), sleep disorder (What is sleep disorder?), cough, hypercalcaemia of malignancy, bronchopneumonia and. Location: SWITZERLAND , 70 years of age, Patient experienced the following unwanted or unexpected effects: agitation, bronchopneumonia, cough, gastrooesophageal reflux disease, grand mal convulsion, hypocalcaemia, hypothyroidism, overdose. During the same period patient was treated with ACIDUM FOLICUM STREULI (5 Mg/d) (View Acidum Folicum Streuli Review and Acidum Folicum Streuli Label ), DISTRANEURIN (300 Mg/d) (View Distraneurin Review and Distraneurin Label ), RESYL (60 Drops/d) (View Resyl Review and Resyl Label ), HAEMODIALYSIS (View Haemodialysis Review and Haemodialysis Label ), ZOMETA (4 Mg) (View Zometa Review and Zometa Label ), DEXAMETHASONE (40 Mg) (View Dexamethasone Review and Dexamethasone Label ), LASIX (20 Mg) (View Lasix Review and Lasix Label ), MERONEM (500-2000 Mg/d) (View Meronem Review and Meronem Label ). Patient was hospitalized.

5070937-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatitis, Hyperbilirubinaemia
on Jul 28, 2006 Female patient from FRANCE , 68 years of age, was diagnosed with pyelonephritis and was treated with Dafalgan (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?), hyperbilirubinaemia. Dafalgan dosage: 3 G, Qd. During the same period patient was treated with OFLOCET (400 Mg, Qd) (View Oflocet Review and Oflocet Label ), BISOPROLOL FUMARATE (10 Mg, Qd) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RIFADIN (300 Mg, 6qd) (View Rifadin Review and Rifadin Label ), AMLODIPINE BESYLATE (5 Mg, Qd) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), TAREG (80 Mg, Qd) (View Tareg Review and Tareg Label ). Patient was hospitalized.

5047072-1 | Agranulocytosis
on Jun 28, 2006 Male patient from FRANCE , 45 years of age, weighting 154.3 lb, was treated with Dafalgan (View Usage). After Dafalgan was administered, patient had the following side effects: agranulocytosis. Dafalgan dosage: . During the same period patient was treated with KENACORT (View Kenacort Review and Kenacort Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ). Patient was hospitalized.

4752206-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatitis
Patient was taking Dafalgan (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?) on Mar 22, 2005 from FRANCE Additional patient health information: Female patient , 52 years of age, . Dafalgan dosage: 500 Mg, 6qd. During the same period patient was treated with FRAXIPARINE (0.4 Ml, Qd) (View Fraxiparine Review and Fraxiparine Label ), DUPHALAC (10 G, 6qd) (View Duphalac Review and Duphalac Label ), LIORESAL (15 Mg, Tid) (View Lioresal Review and Lioresal Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

4621748-X | Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatitis, Transaminases Increased
Adverse event was reported on Mar 22, 2005 by a Female patient taking Dafalgan (View Usage) (Dosage: 500 Mg, 6qd) . Location: , 52 years of age, Patient had the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatitis (What is hepatitis?), transaminases increased. During the same period patient was treated with FRAXIPARINE (0.4 Ml, Qd) (View Fraxiparine Review and Fraxiparine Label ), DUPHALAC (10 G, 6qd) (View Duphalac Review and Duphalac Label ), LIORESAL (15 Mg, Tid) (View Lioresal Review and Lioresal Label ). Patient was hospitalized.